Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1188-1190. doi: 10.1017/ice.2019.210. Epub 2019 Aug 5.

Abstract

Patients with carbapenem-resistant Acinetobacter baumannii-positive clinical cultures during a prior hospitalization were screened using high sensitivity methods upon first readmission. Of 38 patients, 31.6% screened positive; 42% screened positive within 2 months from discharge, and 14% screened positive more than 5 months from discharge. Carriage was persistent up to 285 days.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections / diagnosis*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / drug effects
  • Acinetobacter baumannii / isolation & purification*
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / therapeutic use
  • Carrier State / diagnosis*
  • Carrier State / microbiology
  • Drug Resistance, Bacterial*
  • Female
  • Humans
  • Israel
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Patient Readmission / statistics & numerical data*

Substances

  • Anti-Bacterial Agents
  • Carbapenems